| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 04/13/2005 | CN1606555A Imidazoquinoline derivatives |
| 04/13/2005 | CN1606554A Beta-lactamyl vasopressin v1aantagonists |
| 04/13/2005 | CN1606457A Methods for sterilizing preparations containing albumin |
| 04/13/2005 | CN1606455A Lyophilized preparation containing antibodies to the egf receptor |
| 04/13/2005 | CN1606453A Cripto blocking antibodies and uses thereof |
| 04/13/2005 | CN1606450A Polypeptide, the conjugate thereof with doxorubicin and a pharmaceutical composition based thereon |
| 04/13/2005 | CN1606449A Improved use of antitumoral compound in cancer therapy |
| 04/13/2005 | CN1606444A Inhibitors of human phosphatidyl-inositol 3-kinase delta |
| 04/13/2005 | CN1606439A Cis-imidazolines |
| 04/13/2005 | CN1605589A PC-1 gene promoter and its application |
| 04/13/2005 | CN1605356A Preparation process and prescription of oleum fructus bruceae containing microemulsion |
| 04/13/2005 | CN1605334A Usage of composition in preparing medicine for tumorous disease treatment |
| 04/13/2005 | CN1196784C Promoter of human endoglin gene and its use |
| 04/13/2005 | CN1196708C Glucopyranosides conjugates of 2-(4-hydroxy-phenyl)-1-[4-(2-amin-1-yl-ethoxy)-benzyl)-1h-indol-5-ols |
| 04/13/2005 | CN1196703C Pyrazolobenzodiazepines as CDK2 inhibitors |
| 04/13/2005 | CN1196698C Epothilone C. D. E and F, production process, and their use as cytostatic as well as phytosanitary agents |
| 04/13/2005 | CN1196687C Inhibitors of IMPDH enzyme |
| 04/13/2005 | CN1196685C Pyrimidine derivatives |
| 04/13/2005 | CN1196498C Preparing box for polysaccharide compounding substance |
| 04/13/2005 | CN1196484C Medical compositions for combinant use as anticancer atent |
| 04/12/2005 | US6878834 Selectively reduced to the corresponding hydroxy group |
| 04/12/2005 | US6878746 Treating cancer |
| 04/12/2005 | US6878726 For therapy and prophylaxis inflammation, other inflammation associated disorders, such as arthritis, neurodegeneration and colon cancer, in mammals, dogs, cats or livestock animals |
| 04/12/2005 | US6878725 Serine protease inhibitors |
| 04/12/2005 | US6878720 VEGF receptor tyrosine kinase inhibitors |
| 04/12/2005 | US6878714 Prophylaxis and treatment of angiogenesis mediated diseases such as cancer |
| 04/12/2005 | US6878709 Treating acute and chronic inflammatory disorders and cancer. |
| 04/12/2005 | US6878701 Potassium channel blocking agents |
| 04/12/2005 | US6878688 Method of treatment of malignant neoplasms and complex preparation having antineoplastic activity for use in such treatment |
| 04/12/2005 | US6878544 Retinal cell lines with extended life-span and their applications |
| 04/12/2005 | US6878541 Papilloma pseudo-virus and preparation |
| 04/12/2005 | US6878529 Compounds for the treatment of sexual dysfunction |
| 04/12/2005 | US6878526 Treating cancer |
| 04/12/2005 | US6878375 HA-1 antigen |
| 04/12/2005 | CA2278106C Tissue factor methods and compositions for coagulation and tumor treatment |
| 04/12/2005 | CA2203936C Boronic ester and acid compounds, synthesis and uses |
| 04/12/2005 | CA2123363C Lysosomal enzyme-cleavable antitumor drug conjugates |
| 04/12/2005 | CA2122571C Adhesion receptor antagonists |
| 04/07/2005 | WO2005031347A1 Methods |
| 04/07/2005 | WO2005030955A1 Protein expressed in nk cell |
| 04/07/2005 | WO2005030953A1 Tetrahydrofolate synthase gene |
| 04/07/2005 | WO2005030805A1 Novel protein complex and use thereof |
| 04/07/2005 | WO2005030803A1 Therapeutic molecules |
| 04/07/2005 | WO2005030779A2 Laulimalide analogs with anti-cancer activitity |
| 04/07/2005 | WO2005030776A1 Pyrazolopyrrole derivatives as protein kinase inhibitors |
| 04/07/2005 | WO2005030775A1 6-[(substituted)phenyl]triazolopyrimidines as anticancer agents |
| 04/07/2005 | WO2005030767A1 Novel macrocycles for treating tumor diseases |
| 04/07/2005 | WO2005030765A1 Quinazoline derivatives as antiproliferative agents |
| 04/07/2005 | WO2005030757A1 Quinazoline derivatives |
| 04/07/2005 | WO2005030721A1 Piperidine derivative |
| 04/07/2005 | WO2005030707A1 Reduced hydrazinopeptoids and use thereof in the treatment of cancer |
| 04/07/2005 | WO2005030705A1 Inhibitors of histone deacetylase |
| 04/07/2005 | WO2005030704A1 Inhibitors of histone deacetylase |
| 04/07/2005 | WO2005030676A1 Methods of [11c]-radiolabelling phenothiazine and phenothiazine-like compounds |
| 04/07/2005 | WO2005030329A1 Method of damaging biomolecule and biomolecule damaging apparatus |
| 04/07/2005 | WO2005030260A1 Bispecific oligonucleotide for the treatment of cns malignancies |
| 04/07/2005 | WO2005030248A1 Clostridium botulinum c3 exotransferase compositions and methods for treating tumour spreading |
| 04/07/2005 | WO2005030238A1 Peptides having, for example, an antiangiogenic activity and applications thereof in therapeutics |
| 04/07/2005 | WO2005030235A1 Method of processing ginseng for medicinal use and composition |
| 04/07/2005 | WO2005030225A2 Method of inhibiting the expression of a multi-drug resistance genes and inhibiting the production of proteins resulting from the expression of such genes thereby enhancing the effectiveness of chemotherapeutic agents to treat cancers |
| 04/07/2005 | WO2005030218A1 6-aryl-7-halo-imidazo[1,2-a]pyrimidines as anticancer agent |
| 04/07/2005 | WO2005030216A1 5-arylpyrimidines as anticancer agents |
| 04/07/2005 | WO2005030198A1 Medicinal composition for treatment for fatty liver or liver disease |
| 04/07/2005 | WO2005030124A2 Antibodies to m-csf |
| 04/07/2005 | WO2005029963A1 Hippophae rhamnoides compositions for cancer therapy |
| 04/07/2005 | WO2005012305A3 Tricyclic parp inhibitors |
| 04/07/2005 | WO2005012269A8 Novel azole compound |
| 04/07/2005 | WO2005012256A8 3, 4-disubstituted 1h-pyrazole compounds and their use as cyclin dependent kinases (cdk) and glycogen synthase kinase-3 (gsk-3) modulators |
| 04/07/2005 | WO2005009975A3 Benzimidazole derivatives as mek inhibitors |
| 04/07/2005 | WO2005001778A3 Biologically active neopeltolide compounds |
| 04/07/2005 | WO2004096206A3 Therapeutic combination of a cox-2 inhibitor and a tace inhibitor |
| 04/07/2005 | WO2004066947A3 Hyperthermia oncolysis co-therapy |
| 04/07/2005 | WO2004029092A8 Antibody for adcc and inducing cytokine production |
| 04/07/2005 | WO2004013309A3 PAPSSs AS MODIFIERS OF THE AXIN PATHWAY AND METHODS OF USE |
| 04/07/2005 | WO2004006847A3 Selected antibodies and duramycin peptides binding to anionic phospholipids and aminophospholipids and their use in treating viral infections and cancer |
| 04/07/2005 | WO2004001072A3 Method for diagnosis of colorectal tumors |
| 04/07/2005 | WO2003072063A3 Amino-substituted sulfonanilides and derivatives thereof for treating proliferative disorders |
| 04/07/2005 | US20050075516 Anticarcinogenic agents formed by phosphorylation |
| 04/07/2005 | US20050075499 For therapy of cancer |
| 04/07/2005 | US20050075489 DSP-5 dual-specificity phosphatase |
| 04/07/2005 | US20050075386 Drugs from indocasbazole derivatives |
| 04/07/2005 | US20050075373 Diaryl 1,2,4-triazole derivatives as a highly selective cyclooxygenase-2 inhibitor |
| 04/07/2005 | US20050075357 5-arylpyrimidines as anticancer agents |
| 04/07/2005 | US20050075353 Quinazolines and therapeutic use thereof |
| 04/07/2005 | US20050075349 Xanthine phosphodiesterase V inhibitors |
| 04/07/2005 | US20050075340 Triazolotriazine compounds and uses thereof |
| 04/07/2005 | US20050075339 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| 04/07/2005 | US20050075338 5-(Substituted oxazolyl- or thiazolyl-ethoxy)indaneacetic acid derivatives, used in the treatment of diseases such as diabetes, obesity, hyperlipidemia, and atherosclerotic diseases |
| 04/07/2005 | US20050075337 Pharmaceutical compositions including carotenoid analogs or derivatives for the inhabition and amelioration of disease |
| 04/07/2005 | US20050075334 Novel compounds |
| 04/07/2005 | US20050075330 Dipeptidyl peptidase inhibitors |
| 04/07/2005 | US20050075329 S-tofisopam, a prodrug or a salt thereof, free of its R enantiomer, and a carrier; may also contain one or more other anticonvulsants |
| 04/07/2005 | US20050075315 Antitumor agent |
| 04/07/2005 | US20050075305 Therapeutic compositions and methods of treating glycolipid storage related disorders |
| 04/07/2005 | US20050075295 Combination comprising combretastatin and anticancer agents |
| 04/07/2005 | US20050075272 Pyrimido compounds having antiproliferative activity |
| 04/07/2005 | US20050075268 cell is contacted with a photosentistising agent, cell is irradiated with light to activate photosentisitising agent, the cell is contacted with the molecule to be introduced, particularly for use in cancer treatment, gene therapy and vaccination |
| 04/07/2005 | US20050074879 Antisense oligonucleotide modulation of STAT3 expression |
| 04/07/2005 | US20050074849 Peptides |
| 04/07/2005 | US20050074843 Glycosylation engineering of antibodies for improving antibody-dependent cellular cytotoxicity |